CN102552996A - Personal lubricant - Google Patents

Personal lubricant Download PDF

Info

Publication number
CN102552996A
CN102552996A CN2010105919565A CN201010591956A CN102552996A CN 102552996 A CN102552996 A CN 102552996A CN 2010105919565 A CN2010105919565 A CN 2010105919565A CN 201010591956 A CN201010591956 A CN 201010591956A CN 102552996 A CN102552996 A CN 102552996A
Authority
CN
China
Prior art keywords
human body
extract
androgen
plant extract
body lubricants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN2010105919565A
Other languages
Chinese (zh)
Inventor
宁小静
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN2010105919565A priority Critical patent/CN102552996A/en
Publication of CN102552996A publication Critical patent/CN102552996A/en
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention provides a personal lubricant which is characterized in that the personal lubricant comprises a plant extract with a testosterone-like effect or a plant extract with a testosterone-like effect and a plant extract with a estrogen-like effect. Compared with the existing common products, the personal lubricant has the advantages that functions of the personal lubricant are further enriched, sex hormone can be more thoroughly supplied to women, the personal lubricant has a balancing action on the hormone of women, sexual life quality of women can be further improved, and the personal lubricant does not have toxic or side effects and dependence.

Description

Human body lubricants
Technical field
The present invention relates to human body lubricants, be specifically related to a kind ofly can be that the women replenishes the androgenic multifunctional human lubricant of vegetalitas.
Background technology
Chinese patent number is that 2004100359400 patent discloses a kind of soybean extract and hyaluronic human body lubricants of containing; Its technical scheme is that these three kinds of material compatibilities of soybean lecithin, soybean isoflavone and hyaluronic acid are processed human body lubricants; Solve the women to greatest extent because of involutional former thereby the vaginal dryness disease that occurs, pruritus etc.; From its technical scheme, many deficiencies that it has remedied common human body lubricants have obtained challenging technique effect.
But; Find according to a large amount of medical researches; The women causes its ovarian function to be faded, libido is low, the reason of vaginal dryness after entering into the climacteric period, and is not to cause because of intravital decrease in estrogen fully; Here it is, and the decline of androgen level also is to cause the women to suffer from the indispensable factor of above-mentioned disease.
Androgen is the assembly of a series of hormones in fact, specifically comprises testosterone, androstenedione and dehydroepiandros-sterone, and what wherein output was maximum, effect is the strongest is testosterone.Man's androgen is mainly by testicular secretion.Though the women does not have testis, ovary and adrenal gland can produce androgenic function, medically be called in the gland synthetic.In addition, fat, muscle etc. are organized also and can be produced a small amount of androgen through synthesizing in the gland.Medical science shows that androgen can let women's sebum increase now, forms distinctive graceful curve.The intravital androgen of women is high more, and libido is hoped just strong more, the also easier voluptus that obtains satisfaction.Therefore, the women for being about to get into or entered into the climacteric period except complementing estrogen, gives an amount of androgen, and the satisfaction of its sexual experience will obviously strengthen.
Does the low problem of androgen appear in which type of women especially easily? One type is the women who gets into climacteric more than 35 years old; Especially official holiday begins to move towards irregular women; Because this moment, ovary was not ovulated probably; Ovary also just can not be secreted the Progesterone of capacity and offset estrogenic effect, thereby causes high-caliber estrogen.In case and estrogen is preponderated, will have influence on androgenic output, that is to say have too many women to have the low-level risk of androgen.
Also have, another kind of then is the women of high pressure, and the androgen in view of about 50% is produced by the adrenal gland, and is in the women under the high pressure, and cause androgen to descend because the adrenal gland is depleted also more and more general.
Therefore, in human body lubricants, it is not enough merely adding phytoestrogen.If a kind of can putting on market to the additional androgenic lubricant of women arranged, will satisfy the urgent needs that lacks androgenic female friend.If a kind ofly both can replenish androgen to the women and have, lubricant that again can complementing estrogen is put on market, with further satisfying the urgent needs that lacks androgen and estrogenic female friend.
Summary of the invention
The present invention is in order to solve the deficiency of above-mentioned common human body lubricants, can to replenish the androgenic human body lubricants of vegetalitas for the women and provide a kind of.
The present invention realizes through following technical scheme:
A kind of human body lubricants is characterized in that, it contains the plant extract with androgen-like action or contains plant extract with androgen-like action and the plant extract with estrogen-like effects.
Said human body lubricants also contains hyaluronate sodium.
Said plant extract with androgen-like action is Herba Epimedii extract and/or Rhizoma Dioscoreae extract.
Said plant extract with estrogen-like effects is Radix Puerariae extract puerarin, Herba Trifolii Pratentis extract, genistein, Radix Angelicae Sinensis extract or Semen Sesami lignan.
Said human body lubricants also contains vasodilator active compound, antiviral agents, antimicrobial drug and/or antibiotic medicine.
Said vasodilator active compound is nitrate, ergot alkaloid, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin and phosphodiesterase inhibitor.。
Said antimicrobial drug is an interferon.
Said antimicrobial drug is that benzene is pricked one or more in bromine sodium, Galla Chinensis extract, the Flos Lonicerae extract.
The application of plant extract in human body lubricants with androgen-like action.
Plant extract and the application of plant extract in human body lubricants with androgen-like action with androgen-like action.
Plant extract among the present invention and plant extract with estrogen-like effects with androgen-like action; It is natural sex hormone with hormonelike " dual regulation "; Not only can be women's complementarity hormone effectively; The intravital hormone of women is played balanced action, and have no side effect and dependency, can separate kind women's life quality safely and effectively.
The main effect of raw material is following among the present invention:
Plant extract and plant extract with androgen-like action with estrogen-like effects; Be from the specified plant of occurring in nature, to extract; Phytohormone with the effect of endogenous hormone appearance; It gets in the vagina histiocyte through cell membrane; Hormone receptor combines organ is carried out gentleness and permanent " two-ways regulation " effect, intravital sex hormone level is improved or restores balance, and prevents that ovary from failing, keeping normal physiological function too early, the effect of the vigor of renewing one's youth thereby reach.
Its " two-ways regulation " acts on as follows: when the body inner estrogen was not enough, the plant extract with estrogen-like effects can occupy estrogen-like effects; Secrete when too high when the body inner estrogen, it can combine with self estrogen receptor site, and self estrogen is lost activity, and shows as the reduction estrogen action.Otherwise when in the body during hypoandrogenism, the plant extract with androgen-like action can occupy androgen-like action; Secrete when too high when androgen in the body, it can combine with self androgen receptor site, and self androgen is lost activity, and shows as the reduction androgenic effect.
In addition, contain flavonoid substance in the plant extract with androgen-like action and the plant extract with estrogen-like effects, make its also have below wholesome effect:
1, strong antioxidant action: can remove the generation of reactive oxygen free radical, prevention lipid peroxidation and the chain reaction of blocking-up lipid peroxidation, prevent the too early decline of ovary, postpone the arrival of Women.
2, improve skin quality: can active cell, dermis thickness is increased, pin deep layer moisture, make skin of vulva lubricated soft.
3, antitumor action: the growth to multiple cancerous cell (ovarian cancer, carcinoma of endometrium, cervical cancer) has obvious inhibitory action or inducing death of neoplastic cells.
As a kind of natural plant extracts, plant androgen and phytoestrogen do not have the side effect and the contraindication of artificial synthetic hormone replacement therapy, thereby can solve a series of health problems that the women descends and brings because of sex hormone level safely.
The present invention compares with existing mill run, has the following advantages:
1, further enriched the function of human body lubricants.
2, can more fully be women's complementarity hormone, the intravital hormone of women is played balanced action.
3, can further separate kind women's life quality.
4, have no side effect and dependency.
The specific embodiment
Below in conjunction with specific embodiment the present invention is described further:
Embodiment 1: in 100 milliliters of human body lubricants, and Herba Epimedii extract 0.15 gram, hyaluronate sodium 0.5 gram, sodium oxide 0.5 gram, Borax 0.05 gram, ethyl hydroxybenzoate 0.03 gram, purified water surplus.
Embodiment 2: in 100 milliliters of human body lubricants, and Herba Epimedii extract 1.5 grams, Radix Puerariae extract puerarin 5.0 grams, hyaluronate sodium 1.0 grams, Galla Chinensis extract 0.1 gram, sodium oxide 0.5 gram, Borax 0.05 gram, ethyl hydroxybenzoate 0.03 gram, purified water surplus.

Claims (10)

1. a human body lubricants is characterized in that, it contains the plant extract with androgen-like action or contains plant extract with androgen-like action and the plant extract with estrogen-like effects.
2. human body lubricants according to claim 1 is characterized in that, also contains hyaluronate sodium.
3. human body lubricants according to claim 1 is characterized in that, said plant extract with androgen-like action is Herba Epimedii extract and/or Rhizoma Dioscoreae extract.
4. human body lubricants according to claim 1 is characterized in that, said plant extract with estrogen-like effects is Radix Puerariae extract puerarin, Herba Trifolii Pratentis extract, genistein, Radix Angelicae Sinensis extract or Semen Sesami lignan.
5. human body lubricants according to claim 1 is characterized in that, also contains vasodilator active compound, antiviral agents, antimicrobial drug and/or antibiotic medicine.
6. human body lubricants according to claim 5; It is characterized in that said vasodilator active compound is nitrate, ergot alkaloid, antihypertensive, long-acting and fugitive α-adrenergic receptor blocker, prostaglandin and phosphodiesterase inhibitor.。
7. human body lubricants according to claim 5 is characterized in that said antimicrobial drug is an interferon.
8. human body lubricants according to claim 5 is characterized in that, said antimicrobial drug is that benzene is pricked one or more in bromine sodium, Galla Chinensis extract, the Flos Lonicerae extract.
9. the application of plant extract in human body lubricants that has androgen-like action.
10. the plant extract and the application of plant extract in human body lubricants that have androgen-like action with androgen-like action.
CN2010105919565A 2010-12-07 2010-12-07 Personal lubricant Pending CN102552996A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN2010105919565A CN102552996A (en) 2010-12-07 2010-12-07 Personal lubricant

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN2010105919565A CN102552996A (en) 2010-12-07 2010-12-07 Personal lubricant

Publications (1)

Publication Number Publication Date
CN102552996A true CN102552996A (en) 2012-07-11

Family

ID=46400441

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2010105919565A Pending CN102552996A (en) 2010-12-07 2010-12-07 Personal lubricant

Country Status (1)

Country Link
CN (1) CN102552996A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109224138A (en) * 2017-07-10 2019-01-18 广州新里好贸易有限公司 It is a kind of with nourish nursing role human body with lubricator

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1655740A (en) * 2002-04-16 2005-08-17 富图拉医药发展有限公司 Condom
US20070275032A1 (en) * 2004-03-05 2007-11-29 Synthes (U.S.A.) Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
CN101237851A (en) * 2005-06-16 2008-08-06 沃纳奇尔科特公司 Estrogen compositions for vaginal administration
WO2010083239A2 (en) * 2009-01-13 2010-07-22 Truitt Edward R Iii Therapeutic modulation of vaginal epithelium boundary lubrication

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1655740A (en) * 2002-04-16 2005-08-17 富图拉医药发展有限公司 Condom
US20070275032A1 (en) * 2004-03-05 2007-11-29 Synthes (U.S.A.) Use Of A Mixture For The Production Of An Agent For Treating Defective Or Degenerated Cartilage In The Production Of Natural Cartilage Replacement In Vitro
CN101237851A (en) * 2005-06-16 2008-08-06 沃纳奇尔科特公司 Estrogen compositions for vaginal administration
WO2010083239A2 (en) * 2009-01-13 2010-07-22 Truitt Edward R Iii Therapeutic modulation of vaginal epithelium boundary lubrication

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
彭珊珊等: "《食品添加剂》", 31 January 2009, article "抗菌药", pages: 35-38 *
韩公羽等: "《植物药黄酮成分与生理生化活性》", 28 February 2010, article "雌激素样作用", pages: 75-78 *
黄德斌等: "《中西医结合药理与临床》", 31 December 2005, article "雄激素样作用", pages: 393-395 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109224138A (en) * 2017-07-10 2019-01-18 广州新里好贸易有限公司 It is a kind of with nourish nursing role human body with lubricator

Similar Documents

Publication Publication Date Title
US6599536B1 (en) Therapy of estrogen-associated disorders
CN103005281A (en) High-nutrient healthcare rice and preparation method thereof
CN105919880A (en) Breast enlargement and beauty cream
JP2021172660A (en) Chinese herbal medicine composition that treats insomnia and regulates renal function and its manufacturing method
CN102525720A (en) Condom and manufacture method thereof
CN109350653A (en) The composition of improvement menopause symptom containing NMN, preparation and the preparation method and application thereof
CN102552996A (en) Personal lubricant
CN102940011A (en) Biscuit containing olive extractive
JP2011102264A (en) Aromatase activator
CN101971988B (en) Prescription for treating female climacteric syndrome
CN100348209C (en) Natural lycopene compound oil preparation and capsule and its preparing method and use
CN101120951B (en) Ovarian moisturing soft capsule and preparing process thereof
CN107028182A (en) A kind of anti-apolexis composition and preparation method
US6673366B1 (en) Breast enhancement system
CN102188000A (en) Male tussah anti-aging functional food for male and production process thereof
CN105456761A (en) External-use composition for sleep improvement and preparation method thereof
CN102524638A (en) Health food formula applicable for ovary maintenance, endocrine modulation, anti-oxidation and senility delay of female and method for preparing health food formula
CN106860293A (en) A kind of compound method of ferment smoothing wrinkle Essence
CN103766636A (en) Fodder for treating pig osteomalacia
CN102440316A (en) Apocynum venetum tea
JP2006131572A (en) Emollient for menstruation-related symptom
CN105456101A (en) Skin whitening cosmetic product containing radix rhodiolae extract, radix puerariae extract and lucid ganoderma extract
AU753005B2 (en) Therapy of estrogen-associated disorders
van Die Phytoestrogens in menopause
KR20220019458A (en) Health supplements for improving menopausal symptoms and manufacturing method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20120711